Stock

TriSalus Life Sciences Inc.

000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol TLSI:xnas
Currency USD
united-states
NASDAQ
Open Closed
15 minutes delayed
Data provided by Cboe Global Markets
This information is not currently available for this instrument. Refresh the page or try again later.

Chart

This information is not currently available for this instrument. Refresh the page or try again later.
Open account to access more charting and analysis tools

Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer

About TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Sector Healthcare
Industry -
Market cap 0.23602964bn
Data provided by Morningstar / FactSet Research Systems

Frequently asked questions

To buy TriSalus Life Sciences Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for TriSalus Life Sciences Inc. by name or ticker, choose the number of shares, and place your order.

Learn about Saxo accounts.

The ticker symbol for TriSalus Life Sciences Inc. is TLSI:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.

TriSalus Life Sciences Inc. has its primary listing on NASDAQ. You can trade TriSalus Life Sciences Inc. with a Saxo account, alongside thousands of other stocks worldwide.

Yes, TriSalus Life Sciences Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include TriSalus Life Sciences Inc. as part of a broader investment portfolio.

Explore our SaxoInvestor platform.

Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like TriSalus Life Sciences Inc. or others.

Saxo Bank A/S (Headquarters)
Philip Heymans Alle 15
2900 Hellerup
Denmark

Contact Saxo

International
International

All trading and investing comes with risk, including but not limited to the potential to lose your entire invested amount.

Information on our international website (as selected from the globe drop-down) can be accessed worldwide and relates to Saxo Bank A/S as the parent company of the Saxo Bank Group. Any mention of the Saxo Bank Group refers to the overall organisation, including subsidiaries and branches under Saxo Bank A/S. Client agreements are made with the relevant Saxo entity based on your country of residence and are governed by the applicable laws of that entity's jurisdiction.

Apple and the Apple logo are trademarks of Apple Inc., registered in the US and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.